Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,611.20
(
0.27%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.63
(
-2.44%
)
Bitcoin
70,508.74
(
-1.20%
)
News Focus
News Focus
Post# of 828657
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dennisdave

Send PM Follow Ignore
Followers 42
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

dennisdave

Re: hoffmann6383 post# 534468

Thursday, 11/17/2022 6:15:14 PM

Thursday, November 17, 2022 6:15:14 PM

Post# of 828657
yes but his last straw argument is now that IA showed that endpoints needed to be changed in order to get efficiency on new endpoints so they changed the endpoints, which will not be permitted by the FDA. If that was the reason, then still its absolute BS since the FDA permits endpoint changes ALL the time even if the reason is on blinded IA. Ex last hope is FDA will not approve the trial because the bases on which the endpoints were changed are corrupt. Complete nonsense.

There are many good articles on how to change endpoints in a medical trials.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News